SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-031764
Filing Date
2017-05-11
Accepted
2017-05-11 09:09:11
Documents
4
Period of Report
2017-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-12375_38k.htm 8-K 42008
2 EX-1.1 a17-12375_3ex1d1.htm EX-1.1 222237
3 EX-5.1 a17-12375_3ex5d1.htm EX-5.1 11624
4 GRAPHIC g123753kii001.jpg GRAPHIC 5168
  Complete submission text file 0001104659-17-031764.txt   284515
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 17832684
SIC: 2834 Pharmaceutical Preparations